Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 65

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 65
---
;                    |

| ● | the price or prices at which                
 such warrants will be issued and exercised; |

| ● | the currency or currencies in                     
 which the price of such warrants will be payable; |

| ● | the securities purchasable upon 
 exercise of such warrants;      |

| ● | the date on which the right                                                             
 to exercise such warrants shall commence and the date on which such right shall expire; |

| ● | if applicable, the minimum or                                           
 maximum amount of such warrants which may be exercised at any one time; |

| ● | if applicable, the designation                                                                                                  
 and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; |

| ● | if applicable, the date on and                                                        
 after which such warrants and the related securities will be separately transferable; |

| ● | information with respect to    
 book-entry procedures, if any; |

| ● | any material Israeli and United         
 States federal income tax consequences; |

| ● | the anti-dilution provisions 
 of the warrants, if any; and |

| ● | any other terms of such warrants,                                                                   
 including terms, procedures and limitations relating to the exchange and exercise of such warrants. |

Amendments and Supplements to Warrant Agreement

We and the warrant agent may
amend or supplement the warrant agreement for a series of warrants without the consent of the holders of the warrants issued thereunder
to effect changes that are not inconsistent with the provisions of the warrants and that do not materially and adversely affect the interests
of the holders of the warrants.

<div align='center'>8

DESCRIPTION OF DEBT SECURITIES</div>

The following description,
together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes certain
general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series
of debt securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the
supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities.

We may issue debt securities
either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus.
Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to
this prospectus,